Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options

<div>Representative samples of MALAT1 and BACH1 immunohistochemical expression in TNBC. (a) A case of positive MALAT1 immunoreactivity with strong nuclear expression (400x). (b) The previous case shows negative BACH1 expression. (c) A case of TNBC shows negative MALAT1 expression (400x). (d) The previous case shows positive BATCH1 immunoreactivity with moderate nuclear and cytoplasmic expression (400x). (e) A case of positive MALAT1 immunoreactivity with moderate expression (200x). (f) The previous case shows positive BATCH1 immunoreactivity with strong expression (200x).</div>

International Journal of Breast Cancer

fig2

Figure 2

Figure 2: Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options 

Figure 2 | Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options 